Jennifer A. DoudnaIn 2011, Rachel and I founded a company called Caribou Biosciences to commercialize the Cas proteins.
About This Quote
In 2011, Rachel and I founded a company called Caribou Biosciences to commercialize the Cas proteins. In addition to our Cas protein discovery, we have a proprietary technology that allows us to produce large quantities of the protein in a highly efficient manner. This high quality, large-scale production has been instrumental in advancing the field of regenerative medicine.
Source: A Crack In Creation: Gene Editing And The Unthinkable Power To Control Evolution
Some Similar Quotes
- The problem, often not discovered until late in life, is that when you look for things in life like love, meaning, motivation, it implies they are sitting behind a tree or under a rock. The most successful people in life recognize, that in life they...
- And sometimes I believe your relentless analysis of June leaves something out, which is your feeling for her beyond knowledge, or in spite of knowledge. I often see how you sob over what you destroy, how you want to stop and just worship; and you...
- The saddest aspect of life right now is that science gathers knowledge faster than society gathers wisdom.
- I'm sure the universe is full of intelligent life. It's just been too intelligent to come here.
- A man who dares to waste one hour of time has not discovered the value of life.
More Quotes By Jennifer A. Doudna
- In 2011, Rachel and I founded a company called Caribou Biosciences to commercialize the Cas proteins.
- Editas Medicine has an exclusive multimillion-dollar license with Juno Therapeutics to develop T cell therapies
- PGD has also been used for other controversial purposes, such as the birth if so-called savior siblings, destined from the moment of implantation not only to live their own lives, but also to serve as organ or cell donors for a sibling.
- We founded Editas Medicine with $43 million in financing from three venture capital firms.
- As we began discussing authorship of a white paper summarizing our conclusions, we debated who our target audience should be and what kind of outcome we were hoping to achieve.